Stay updated on Ziltivekimab in Cardiovascular & Kidney Disease Clinical Trial
Sign up to get notified when there's something new on the Ziltivekimab in Cardiovascular & Kidney Disease Clinical Trial page.

Latest updates to the Ziltivekimab in Cardiovascular & Kidney Disease Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.3.3) was added to the page history, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded Contacts/Locations and Study Status to the record history in the latest update (2025-12-02); the earlier addition is shown as version 71 on 2025-11-29, and a deletion occurred on 2025-09-25.SummaryDifference0.2%

- Check35 days agoChange DetectedAn additional revision entry v3.3.2 was added and v3.2.0 removed in the history; this affects only revision metadata and not the study information.SummaryDifference0.0%

- Check42 days agoChange DetectedOn the old version, a government funding status banner was displayed; the new version no longer displays this banner. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check56 days agoChange DetectedNew version entries were added to the Record History, showing recent revisions to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference8%

Stay in the know with updates to Ziltivekimab in Cardiovascular & Kidney Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziltivekimab in Cardiovascular & Kidney Disease Clinical Trial page.